I See Some Magic Happening as Psilocybin Advances
New technology could take out some of the pain -- and subjectivity -- for those looking to invest in this emerging line of treatments.
Abbott Labs Earnings Are Astounding! Here's My Trade Idea
ABT reported its third quarter financial performance on Wednesday morning.
A Correction in the Share Price of Tenet Healthcare Appears Over
Let's take a look at the charts and indicators.
UnitedHealth Group Shares Are on the Move Up
Let's check on the charts and indicators.
Have Patience as NovoCure Looks for a New Bottom Pattern
Let's review the charts and indicators.
The Hammer Bottom Reversal on Sharecare Turned Me Bullish
Here's our price objective for now.
Clinically Speaking: 6 Stocks Behind the Scenes at Drug Trials
Investors are increasingly looking to the companies involved in clinical trials. Here are six favorite names in this space.
Prospective Pickings Are Slim for This Annual Portfolio of Unloved Losers
The current candidates for the 2022 Tax-Loss Selling Recovery Portfolio are few and far between, with only a couple households names in the bunch.
Here's Why Paratek Pharmaceuticals Is the Only Antibiotic Name in My Portfolio
The economics of this space is not nearly as favorable as the outcomes these drugs achieve in medical settings.
3 Smaller Healthcare Stocks That Still Look Like Values in a Pricey Market
ProQR Therapeutics, Oscar Health and Hims & Hers Health appear to have promising futures.